secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001013762-23-007388
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed Pharmaceuticals raises $5.2M through private placement and option exercise
--------------------------------------------------------------------------------

- Gross proceeds ~$5.2M from sale of 3,012,049 pre-funded warrants and options; existing holders exercised 3,272,733 options at $0.83.
- Issued new preferred investment options to purchase up to 6,545,466 shares at $0.83, exercisable immediately, expire in 5.5 years.
- H.C. Wainwright acted as exclusive placement agent; received 7.5% cash fee and warrants for 408,511 shares at $1.0375.
- Proceeds to fund pipeline development, BayMedica commercial sales, and general working capital.
- Securities unregistered; company to file resale registration statement within 50-80 days of closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000101376223007388/0001013762-23-007388-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000101376223007388/ea187408-8k_inmedpharm.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-007388

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer